Search
Resonance chief scientific officer Tim St Pierre.

Resonance surges on UK approval

Shares in Resonance Health jumped 53 per cent today after its FerriScan technology was recommended for use under a new set of medical guidelines in the UK.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/12/18

1 year TSR5 year TSR
20thResonance Health200%2%
566thAffinity Energy and Health-46%-39%
680thSpectur-60%
741stRewardle Holdings-69%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

06/09/18
$32k Bought
29/05/18
$2k Bought
23/05/18
$4k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

117th↓Resonance Health$2.9m
121st↓Affinity Energy and Health$2.6m
122nd↓Rewardle Holdings$2.6m
124th↓Crowdspark$2.5m
125th↑Spectur$2.5m
237 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer